- All
- #InspiredByLife
- Bioeconomy
- Biosimilars
- BREXIT
- Cell & Gene Therapies
- Circular Economy
- Climate Change
- COVID-19
- Factsheet
- Genome editing
- HEALTHCARE BIOTECH
- INDUSTRIAL BIOTECH
- Innovation
- Intellectual Property
- Interview
- Jobs & Growth
- NATIONAL ASSOCIATIONS
- News
- Other
- Patient Bio-Forum
- Position Paper
- Press release
- Public Procurement
- Regulatory Efficiency
- Report
- SME
- SME Platform
- WHAT IF
- White paper
May 7, 2021
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency.
May 4, 2021
EuropaBio sat down with new corporate member Kaffe Bueno, to find out more about the future of coffee.
May 4, 2021
EuropaBio is delighted to announce that Kaffe Bueno joined the association as a corporate member.
April 28, 2021
EuropaBio sat down with new National Association Member from Lithuania.
April 21, 2021
EuropaBio sat down with new National Association Member from Bulgaria, to find out their plans for their national activities within an international framework.
April 14, 2021
EuropaBio sat down with new Member UNION Therapeutics, to find out about its novel anti-infective programme and how it can support Covid treatment in vulnerable patients.
April 14, 2021
EuropaBio is delighted to announce that UNION Therapeutics has joined the association as a corporate member.
April 6, 2021
EuropaBio sat down with new Member Inscripta, to find out what gets them fired up with their ground breaking ‘benchtop biofoundry’ Onyx™.
April 6, 2021
EuropaBio is delighted to announce that Inscripta has joined EuropaBio as an associate member.
March 31, 2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
March 29, 2021
EuropaBio is delighted to announce that Abolis has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor.
March 25, 2021
EuropaBio Statement – Vaccine production scale up: International collaboration remains the key.
March 22, 2021
EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe
March 15, 2021
Abolis joins EuropaBio: Sustainable Bio-Based Products.
March 9, 2021
EuropaBio is delighted to announce that Catalent has joined EuropaBio’s 25th Anniversary Celebration Programme as a major sponsor.